A Danish eye-care company’s use of celebrity endorsements on social media has reignited a fundamental debate at the intersection of healthcare regulation, influencer marketing, and corporate responsibility. The case illustrates not only a legal misstep, but a broader governance challenge facing Nordic healthcare brands operating in an increasingly digital, personality-driven media landscape.
The Case: When Promotion Becomes Prohibited Advertising
EuroEyes, a company founded in Denmark and now operating clinics across Europe and China, has in recent years featured well-known Danish public figures in Instagram videos describing their positive experiences with eye surgery. Among them were former football star Michael Laudrup, actor Gordon Kennedy, and TV chef Henrik Boserup.
In the videos, the celebrities describe their lives after surgery—free from glasses and limitations—often in upbeat, emotionally engaging terms. According to multiple legal experts, this format violates Danish regulations on healthcare marketing.
Under Danish law, healthcare providers are prohibited from marketing medical treatments using moving images on platforms other than their own websites. The restriction applies regardless of whether the content is factual, testimonial-based, or paid. Social media platforms such as Instagram and YouTube are explicitly excluded.
Three independent experts—Heidi Højmark Helveg (3H Law), Daniel Mathias Bager (Danish Consumer Council Think), and Kent Kristensen (Aalborg University)—reviewed more than 20 videos and unanimously concluded that the material constituted illegal advertising.
Why the Rules Exist: Consumer Protection Over Persuasion
The rationale behind Denmark’s strict healthcare marketing rules is consumer protection. Medical decisions are fundamentally different from consumer choices about lifestyle products. Emotional storytelling, celebrity influence, and aspirational framing can obscure risk, nuance, and medical uncertainty.
As Marijke Vittrup, Director of the Danish Eye Association, noted, the videos present eye surgery as a “hurray experience,” focusing exclusively on positive outcomes while omitting potential risks and complications.
“We are very good at performing these procedures today,” she explained, “but they are not risk-free. This is surgery. It involves replacing the eye’s natural lens. That reality disappears when famous faces ‘blue-stamp’ the procedure.”
From a regulatory standpoint, the issue is not the truthfulness of the testimonials, but the medium and emotional framing used to communicate them.
Celebrity Marketing: A High-Risk Strategy in Regulated Industries
From a business perspective, the case highlights a structural risk for healthcare companies adopting influencer-style marketing strategies borrowed from consumer brands.
Celebrity endorsements are powerful precisely because they shortcut trust. However, in healthcare, that same mechanism can undermine informed consent. Regulators across Europe—particularly in the Nordic countries—are increasingly sensitive to this tension.
Notably:
- Paid endorsements (as confirmed by Michael Laudrup) increase regulatory exposure.
- Unpaid “ambassador” roles (as claimed by Henrik Boserup) do not mitigate legal responsibility.
- Good intentions or post-hoc legal reviews do not substitute for proactive compliance frameworks.
In highly regulated sectors, marketing innovation without regulatory foresight often results in reputational and operational setbacks.
EuroEyes’ Response and Industry Implications
After inquiries from Danish broadcaster DR, EuroEyes conducted a legal review and removed the videos from social media platforms. In a written statement, the company acknowledged that some content may have breached regulations and stated that it is adjusting its marketing practices to ensure full compliance.
This response aligns with a broader trend seen across Europe in 2024–2025: healthcare providers tightening governance around digital communications, especially as regulators increase scrutiny of social media, influencer partnerships, and AI-driven marketing tools.
The episode serves as a cautionary case for healthcare executives, marketing leaders, and boards:
- Compliance must be embedded early in campaign design.
- “Borrowed” marketing tactics from consumer industries rarely translate cleanly into healthcare.
- Brand trust in healthcare is built as much on restraint as on visibility.
Looking Ahead: A Shifting Regulatory and Media Landscape
As social platforms evolve and healthcare companies expand internationally, the tension between growth, branding, and regulation will intensify. Nordic companies, often seen as global benchmarks for ethical business conduct, face particularly high expectations.
The EuroEyes case is less about one company’s error and more about a structural lesson: in healthcare, visibility without balance can quickly become liability.
Editor’s Note – What’s Next?
In our next article, Nordic Business Journal will explore how Nordic healthcare companies can design compliant, trust-based communication strategies in the age of influencers, AI-generated content, and cross-border regulation.
We invite readers to:
- Share perspectives from your own industries
- Suggest cases worth investigating
- Connect with us for collaboration and thought leadership
Connect with Nordic Business Journal
Stay engaged with responsible business reporting, governance insights, and Nordic leadership perspectives.